CorMedix (CRMD) Interest & Investment Income (2010 - 2025)
CorMedix (CRMD) reported Interest & Investment Income of $3.8 million for Q4 2025, up 48.84% on a YoY basis from $2.6 million in Q4 2024, and up 46890.59% sequentially from $8181.0 in Q3 2025.
CorMedix (CRMD) Interest & Investment Income (2010 - 2025) Analysis & Trends
CorMedix (CRMD) has 15 years of Interest & Investment Income data on file, last reported at $3.8 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income rose 48.84% year-over-year to $3.8 million; the trailing twelve-month figure through Dec 2025 stood at $3.8 million (up 11.57% YoY), and the FY2025 full-year result was $3.8 million, up 49.13% from the prior year.
- Interest & Investment Income climbed to $3.8 million in Q4 2025, from $8181.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.8 million in Q4 2025 to a low of -$10732.0 in Q2 2023.
- A 5-year average of $571877.7 and a median of $10966.0 in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 4739.93% in 2023 and sank 197.09% in 2025, its largest moves.
- Tracing CRMD's Interest & Investment Income over 5 years: stood at $4367.0 in 2021, then soared by 4102.08% to $183505.0 in 2022, then soared by 1360.87% to $2.7 million in 2023, then retreated by 3.65% to $2.6 million in 2024, then soared by 48.84% to $3.8 million in 2025.
- Business Quant data shows CRMD's Interest & Investment Income at $3.8 million in Q4 2025, $8181.0 in Q3 2025, and -$1971.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn | 3.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 8,181.00 |
| Jun 30, 2025 | -1,971.00 |
| Mar 31, 2025 | -4,511.00 |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 5,040.00 |
| Jun 30, 2024 | 2,030.00 |
| Mar 31, 2024 | 857,186.00 |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | 765,241.00 |
| Jun 30, 2023 | -10,732.00 |
| Mar 31, 2023 | 446,384.00 |
| Dec 31, 2022 | 183,505.00 |
| Sep 30, 2022 | 15,811.00 |
| Jun 30, 2022 | 35,342.00 |
| Mar 31, 2022 | 13,751.00 |
| Dec 31, 2021 | 4,367.00 |
| Sep 30, 2021 | 3,022.00 |
| Jun 30, 2021 | 3,340.00 |
| Mar 31, 2021 | 3,675.00 |